Topic Archives: Assembly Biosciences (ASMB)

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]

Comments

  • Avatar

    Setting aside how most Gumshoers regard Altucher, SSTI had a wonderful price run up in Jan 2019 and then based/traded si...

  • Avatar

    Travis, Here is a summary of IIPR's recent activity (2/13/19) from Briefing.com which (as it seems to me) is causing the...

  • Travis Johnson, Stock Gumshoe

    I don't like Yahoo Finance much anymore, they no longer collect much useful information outside of the basic fundamental...

  • Travis Johnson, Stock Gumshoe

    My favorite summary sources for that kind of basic info are YCharts and Briefing.com, though neither is free....

  • Avatar

    FYI, I saw a news brief dated 1/9/2018 stating "BIVV ...will acquire all shares in FIVE Inc, making it a subsidiary of t...

  • Travis Johnson, Stock Gumshoe

    Another note about the focus on this sector, from briefing.com this morning: Qualcomm Incorporated (QCOM...

  • Avatar

    $SNNA No Position From Briefing.com STORY STOCKS® | Updated: 21-Aug-17 | Archive | Add to Column Alerts Brief...

  • Avatar

    $ AFMD long From Briefing.com Exelixis (EXEL) initiated with Buy and $33 tgt, Affimed Therapeutics (AFMD) with Buy...

  • Avatar

    $SCYX Briefing.com in-play article: --The first oral presentation (#OS0846) described new data from a multicenter ...

  • Avatar

    $AKAO: -How much weight should one place on financial analyst opinions on stock recommendations? IMO, this provides th...

  • Travis Johnson, Stock Gumshoe

    Here's the first really optimistic growth forecast I've seen for STM lately, based largely on the fact that they've appa...

  • Travis Johnson, Stock Gumshoe

    Update today from Briefing.com: Himax Tech target raised to $14 at Craig Hallum -- It’s looking more an...

  • Avatar

    Actinum Pharma to provide clinical update on Actimab-A at upcoming 2015 ASCO annual meeting on Sunday, May 31 Briefing....

  • Avatar

    Also Robert Re; $NBY Briefing.com is reporting that shares were halted at 3:43PM because of good news. http://finance.y...

  • Avatar

    Akebia Therapeutics misses by $0.02 Briefing.com - 7:05 AM ET, 11/10/2014 Reports Q3 (Sep) loss of $0.47 per share...

  • Avatar

    YES!!!! Durata Therapeutics to be acquired by Actavis (ACT) for $23.00/share in cash, or ~$675 million in the aggregate...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info